249 related articles for article (PubMed ID: 19372139)
21. miR-145 inhibits breast cancer cell growth through RTKN.
Wang S; Bian C; Yang Z; Bo Y; Li J; Zeng L; Zhou H; Zhao RC
Int J Oncol; 2009 May; 34(5):1461-6. PubMed ID: 19360360
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of miR-21 by Ras in vivo and its role in tumor growth.
Frezzetti D; De Menna M; Zoppoli P; Guerra C; Ferraro A; Bello AM; De Luca P; Calabrese C; Fusco A; Ceccarelli M; Zollo M; Barbacid M; Di Lauro R; De Vita G
Oncogene; 2011 Jan; 30(3):275-86. PubMed ID: 20956945
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of microRNA-143 and -145 in human gastric cancers.
Takagi T; Iio A; Nakagawa Y; Naoe T; Tanigawa N; Akao Y
Oncology; 2009; 77(1):12-21. PubMed ID: 19439999
[TBL] [Abstract][Full Text] [Related]
24. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
Kefas B; Godlewski J; Comeau L; Li Y; Abounader R; Hawkinson M; Lee J; Fine H; Chiocca EA; Lawler S; Purow B
Cancer Res; 2008 May; 68(10):3566-72. PubMed ID: 18483236
[TBL] [Abstract][Full Text] [Related]
25. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Chan JA; Krichevsky AM; Kosik KS
Cancer Res; 2005 Jul; 65(14):6029-33. PubMed ID: 16024602
[TBL] [Abstract][Full Text] [Related]
27. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
Pigazzi M; Manara E; Baron E; Basso G
Cancer Res; 2009 Mar; 69(6):2471-8. PubMed ID: 19258499
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.
le Sage C; Nagel R; Egan DA; Schrier M; Mesman E; Mangiola A; Anile C; Maira G; Mercatelli N; Ciafrè SA; Farace MG; Agami R
EMBO J; 2007 Aug; 26(15):3699-708. PubMed ID: 17627278
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Nakamachi Y; Kawano S; Takenokuchi M; Nishimura K; Sakai Y; Chin T; Saura R; Kurosaka M; Kumagai S
Arthritis Rheum; 2009 May; 60(5):1294-304. PubMed ID: 19404929
[TBL] [Abstract][Full Text] [Related]
30. Slowing down the Ras lane: miRNAs as tumor suppressors?
Morris JP; McManus MT
Sci STKE; 2005 Aug; 2005(297):pe41. PubMed ID: 16107327
[TBL] [Abstract][Full Text] [Related]
31. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
Li Y; Tan W; Neo TW; Aung MO; Wasser S; Lim SG; Tan TM
Cancer Sci; 2009 Jul; 100(7):1234-42. PubMed ID: 19486339
[TBL] [Abstract][Full Text] [Related]
32. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
Xia H; Qi Y; Ng SS; Chen X; Li D; Chen S; Ge R; Jiang S; Li G; Chen Y; He ML; Kung HF; Lai L; Lin MC
Brain Res; 2009 May; 1269():158-65. PubMed ID: 19265686
[TBL] [Abstract][Full Text] [Related]
33. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression.
Murata T; Takayama K; Katayama S; Urano T; Horie-Inoue K; Ikeda K; Takahashi S; Kawazu C; Hasegawa A; Ouchi Y; Homma Y; Hayashizaki Y; Inoue S
Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):356-61. PubMed ID: 20820187
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity.
Zhang X; Zhu W; Zhang J; Huo S; Zhou L; Gu Z; Zhang M
Biochem Biophys Res Commun; 2010 Apr; 395(2):275-80. PubMed ID: 20381459
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
Levati L; Alvino E; Pagani E; Arcelli D; Caporaso P; Bondanza S; Di Leva G; Ferracin M; Volinia S; Bonmassar E; Croce CM; D'Atri S
Int J Oncol; 2009 Aug; 35(2):393-400. PubMed ID: 19578755
[TBL] [Abstract][Full Text] [Related]
38. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-223 is a key factor in osteoclast differentiation.
Sugatani T; Hruska KA
J Cell Biochem; 2007 Jul; 101(4):996-9. PubMed ID: 17471500
[TBL] [Abstract][Full Text] [Related]
40. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
